Jenkinson C, Fitzpatrick R, Peto V
Department of Public Health, University of Oxford, England.
Pharmacoeconomics. 1999 Feb;15(2):157-65. doi: 10.2165/00019053-199915020-00004.
Outcome measures are increasingly used to assess the impact of diseases such as Parkinson's disease (PD) from the patient's perspective. These measures, in the form of questionnaires to assess health-related quality of life (HR-QOL), are of 2 main kinds: generic and disease-specific. The former is intended to be relevant to the widest range of health problems; the latter is developed specifically to assess HR-QOL for a specific condition. Possible consequences of PD have been assessed by generic instruments such as the Sickness Impact Profile (SIP), the Nottingham Health Profile (NHP), the Medical Outcomes Study 36-Item Short Form (SF-36) Health Survey and also by disease-specific instruments; in particular, the Parkinson's Disease Quality-of-Life Questionnaire (PDQL) and 39-Item Parkinson's Disease Questionnaire (PDQ-39). This article summarises the criteria whereby such instruments should be evaluated by potential users and describes in more detail the methods of developing and testing such disease-specific instruments for use in PD. There is a range of valid and feasible methods available for taking into account patients' views of PD outcomes. These will become important outcome measures in future clinical trials of treatment regimes.
从患者的角度来看,结局指标越来越多地用于评估帕金森病(PD)等疾病的影响。这些以问卷形式评估健康相关生活质量(HR-QOL)的指标主要有两种:通用型和疾病特异性型。前者旨在适用于最广泛的健康问题;后者则是专门为评估特定疾病的HR-QOL而开发的。PD的可能后果已通过通用工具进行评估,如疾病影响量表(SIP)、诺丁汉健康量表(NHP)、医学结局研究简明健康调查问卷(SF-36),也通过疾病特异性工具进行评估;特别是帕金森病生活质量问卷(PDQL)和帕金森病39项问卷(PDQ-39)。本文总结了潜在使用者评估此类工具应依据的标准,并更详细地描述了开发和测试此类用于PD的疾病特异性工具的方法。有一系列有效且可行的方法可用于考虑患者对PD结局的看法。这些将成为未来治疗方案临床试验中的重要结局指标。